Word

NICKL

Status

Pending

Status Code

630

Status Date

Thursday, August 31, 2023

Serial Number

98152850

Mark Type

4000

Filing Date

Monday, August 28, 2023

Trademark Owner History

ReNAgade Therapeutics Management, Inc.

Classifications

5 Enzymes and nucleic acid sequences for medical use, namely, for the modification of cells and RNA and DNA; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and RNA and DNA editing; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene, genome, and cellular editing, modulation, and modification for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene editing

1 Chemical and biological agents for scientific and research use, namely, for manipulating or modifying RNA and DNA; enzymes for scientific and research purposes; enzyme preparations for use in the gene editing industry; Nucleic acid sequences for other than medical and veterinary purposes

42 Research and development in the field of technology and engineering for the modification of RNA and DNA and gene editing technology; development of new technology for others for enabling the engineering and modification of RNA and DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and RNA and DNA

Trademark Events

Sep 26, 2023

New Application Office Supplied Data Entered

Aug 31, 2023

New Application Entered